Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain 49 is a protein encoded by the WDR49 gene. It contains nine WD40 repeats, which are structural motifs of roughly 40 amino acids that typically end with a tryptophan-aspartic acid (WD) dipeptide. Proteins with WD40 domains are structurally characterized by forming beta-propeller folds that serve as platforms for reversible multi-protein complex assembly, rather than catalytic activity. WDR49 is associated with the nexin-dynein regulatory complex, important for ciliary and flagellar motility, and may act as an inner dynein arm hub or linkage. Members of the WD repeat protein family are implicated in diverse cellular processes such as signal transduction, gene regulation, cell cycle progression, and apoptosis, largely via scaffolding functions that organize and coordinate protein interactions. There is some indication of disease association with prostate cancer, but the functional impact of WDR49 in human disease is not well characterized. There are no known direct drugs, therapeutic mechanisms, or biomarker roles currently established for WDR49.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain 49 (WDR49).